Evidence map›Paper›PMID 23568438›Full record

ArticleJournal of inherited metabolic disease2014

Glutathione metabolism in cobalamin deficiency type C (cblC).

Anna Pastore, Diego Martinelli, Fiorella Piemonte, Giulia Tozzi, Sara Boenzi, Gianna Di Giovamberardino, Sara Petrillo, Enrico Bertini, Carlo Dionisi-Vici

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of inherited metabolic disease, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Cysteamine revisited: repair of arginine to cysteine mutations.Journal of inherited metabolic disease · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anna PastoreLaboratory of Metabolomics and Proteomics, Bambino Gesù Children's Hospital, IRCCS, P.zza S. Onofrio, 4-00165, Rome, Italy, anna.pastore@opbg.net.
Diego Martinelli
Fiorella Piemonte
Giulia Tozzi
Sara Boenzi
Gianna Di Giovamberardino
Sara Petrillo
Enrico Bertini
Carlo Dionisi-Vici

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMethylmalonic aciduria with homocystinuria, cblC defect, is the most frequent disorder of vitamin B12 metabolism. CblC patients are commonly treated with a multidrug therapy to reduce metabolite accumulation and to increase deficient substrates. However the long-term outcome is often unsatisfactory especially in patients with early onset, with frequent progression of neurological and ocular impairment. Recent studies, have shown perturbation of cellular redox status in cblC. To evaluate the potential contribution of oxidative stress into the patophysiology of cblC defect, we have analyzed the in vivo glutathione metabolism in a large series of cblC deficient individuals.

methodsLevels of different forms of glutathione were measured in lymphocytes obtained from 18 cblC patients and compared with age-matched controls. Furthermore, we also analyzed plasma cysteine and total homocysteine.

resultsWe found an imbalance of glutathione metabolism in cblC patients with a significant decrease of total and reduced glutathione, along with a significant increase of different oxidized glutathione forms.

conclusionsThese findings show a relevant in vivo disturbance of glutathione metabolism underlining the contribution of glutathione pool depletion to the redox imbalance in treated cblC patients. Our study may be helpful in addressing future research to better understanding the pathogenetic mechanism of the disease and in developing new therapeutic approaches, including the use of novel vitamin B₁₂ derivatives.

Indexed as

AdolescentAmino Acid Metabolism, Inborn ErrorsCarrier ProteinsCase-Control StudiesChildChild, PreschoolCysteineDisease ProgressionFemaleGlutathioneHomocysteineHomocystinuriaHumansInfantLymphocytesMaleCarrier ProteinsCysteineGlutathioneHomocysteineMMACHC protein, humanOxidoreductasesOxygenReactive Oxygen SpeciesVitamin B 12

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.